The central lesion of infective endocarditis is the vegetation, an infected fibrin-platelet thrombus which forms on the surface of a cardiac valve colonized by circulating microorganisms. Investigations in this laboratory have sought to elucidate the mechanisms of vegetation development, focusing on the thrombotic process, since fibrin is the primary and essential structural component of the lesion (10, 11) . Previous studies, using an animal model of enterococcal endocarditis, identified tissue factor (TF) expression as the primary mechanism of local coagulation activation on infected valves, but the cell types expressing TF were not identified (11) .
TF is the cell-associated activator of the coagulation protease cascade, being a cell surface membrane protein which functions as the receptor and essential cofactor for factor VII (25) . It is not expressed by bacteria or platelets, the primary cellular constituents of the vegetation. Some cells in culture, such as smooth-muscle cells and fibroblasts, are reported to express TF constitutively (22, 29) . Human umbilical vein endothelium in culture expresses TF only following induction by certain mediators such as lipopolysaccharide (LPS) and interleukin-1 (IL-1), suggesting that these normally nonthrombogenic cells may play an active role in thrombosis associated with inflammation (2, 6, 8) . Constituent cells of the cardiac valve were therefore considered to be potential sources of procoagulant activity (PCA) expressed by infected valves.
In this study, both constituent cell types of human cardiac valves, endothelial cells and stromal cells, were isolated and propagated in culture. The procoagulant properties of each were investigated to determine under what conditions TF was expressed, whether TF expression varied among cells derived from different valves, and whether coincubation of cells with streptococci (enterococci and viridans group strains) influenced cellular TF expression. Fresh frozen plasma pooled from 10 donors was prepared as described previously (18) and frozen at -70°C in 1-ml portions. Fibronectin was purified from single-donor fresh frozen plasma obtained from the UCLA Transfusion Service by affinity chromatography, using gelatin-Sepharose 4B columns purchased from Pharmacia, Piscataway, N.J., as described before (13) . Purified factors VIla and X were kindly provided by Daryl Fair of the University of Texas Health Sciences Center in Tyler. Monoclonal antibody to human TF was kindly provided by James Morrissey of the Research Institute of Scripps Clinic, La Jolla, Calif.
Cell culture. Human cardiac valve endothelial cells (HCVE) were derived from cardiac valves of hearts removed during cardiac transplantation, using techniques described for large-vessel endothelium (21, 36, 39) . Cells were grown on fibronectin-coated (5 ,ug/cm2) tissue culture plastic ware in medium 199 supplemented with 25 mM HEPES (N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid), 20% fetal bovine serum, glutamine (292 jig/ml), pyruvate (110 ,ug/ml), penicillin (100 U/ml), streptomycin (100 ,ug/ml), endothelial cell growth supplement (50 ,ug/ml), and heparin (90 ,ug/ml). Cells were passed at 1:2 split ratios and were used for experiments in passages 4 to 6. Cardiac valve stromal cells were obtained by using a technique described for large-vessel smooth-muscle cells, with minor modifications (7) . Following scraping of the valve surfaces to remove endothelium, the valves were finely minced and incubated in a mixture of elastase (0.24 mg/ml), soybean trypsin inhibitor (0.75 mg/ml), collagenase (2.0 mg/ml), and bovine serum albumin (1.0 mg/ml) in medium 199 at 37°C for 90 min with gentle shaking. The (27) . Cell (Fig. la) . Von Willibrand factor was demonstrable in these cells by immunofluorescence, confirming them to be of endothelial origin (Fig. lb) . Stromal cells in culture appeared larger and more spread out, with overlapping growth (Fig. lc) . At confluence, cell densities were 2 x 104 to 4 x 104/cm2. These cells did not contain von Willibrand factor by immunofluorescence (Fig. ld) . cells). Exposure to LPS resulted in significant increases in activity, peaking at 6 to 8 h and declining substantially by 24 h (Fig. 2) . Over the course of this striking functional response, HCVE did not undergo morphologic changes by light microscopy, nor did they detach from the culture dish. Cell viability assessed by trypan blue dye exclusion was >90%. Dose-response determinations demonstrated LPS effects at 0.1 ng/ml and maximal response at .10 ng/ml (Fig.   3 ). PCA of LPS-stimulated HCVE was substantially inhibited (83.5 ± 6.6%) by preincubating cell lysates with a monoclonal antibody to TF prior to PCA assay.
Exposure of HCVE to rIL-la at concentrations of 20 U/ml induced procoagulant responses of comparable magnitude and time course to those induced maximally by LPS. PCAs of HCVE derived from one heart and tested at the same passage were 5,592 ± 1,482 and 5,901 ± 1,497 mU/105 cells when stimulated by LPS and rIL-la, respectively, compared with 99 ± 50 mU for unstimulated HCVE (n = 4; each determined in duplicate). Heat inactivation (15 min, 80°C) completely abolished the procoagulant-inducing activity of rIL-la preparations, indicating that possible contamination by LPS did not cause these responses. Dose-response determinations showed consistent induction of PCA at .0.312 U/ml (Table 1) . Maximal induction occurred at 20 U/ml (40 U/ml was the highest concentration tested).
Examination of procoagulant response to rIL-la for HCVE from each of the cardiac valves did not demonstrate significant differences for either low or high concentrations of the cytokine (Table 2) . In separate experiments, no differences according to valve source were observed for LPS-induced PCA either; results for HCVE from aortic, mitral, pulmonic, and tricuspid valves exposed to 1 Endothelium is now recognized to play a potentially active role in thrombosis (28, 35) . Although normally maintaining a nonthrombogenic surface at the vascular lumen, it may (9, 40) . Thrombin is obviously generated locally, and immune complexes are detectable in the circulation of most patients with infective endocarditis (1) .
Cultured human cardiac valve stromal cells constitutively expressed high levels of TF. These cells have been shown to have characteristics of smooth-muscle cells rather than of fibroblasts, which they morphologically resemble by light microscopy (14) . Both of these cell types in culture have been shown to express relatively high levels of TF constitutively (22, 29) . Valve stromal cells are normally embedded in the internal valve stromal matrix, being separated from the blood by overlying endothelium. However, these cells may become exposed to the vascular lumen in the course of progressive valve damage following bacterial colonization of Nonbacterial thrombotic endocarditis lesions (sterile thrombi on cardiac valves) have been shown to play a critical role in the pathogenesis of most cases of infective endocarditis by serving as the site to which circulating microorganisms adhere, thus initiating the infection (31, 37) . The pathogenesis of these lesions, which occur in a wide range of clinical settings, including intracardiac catheter placement, primary cardiac valve disorders, malignancy, infection, disseminated intravascular coagulation (DIC), and connective-tissue disorders, is not well understood (5, 30) . These studies suggest two potential common mechanisms for local coagulation activation which may be active among these diverse conditions. By analogy with the mechanisms discussed above in infective endocarditis, in cases of nonbacterial thrombotic endocarditis, TF-initiated thrombosis could occur either by valve injury leading to stromal cell exposure or by mediatorinduced TF expression in endothelial cells.
The frequency of valve involvement in both nonbacterial thrombotic endocarditis and infective endocarditis is nonuniform among the four cardiac valves (5, 32) . Except in particular settings, the mitral and aortic valves are far more commonly affected than the tricuspid or pulmonic valves. Since endothelium derived from different vascular sites has been shown to vary in expression of some cell properties, we hypothesized that either qualitative or quantitative differences in TF expression by valve cells might account for the differences in valve involvement observed clinically (17, 34) . However, relative levels of TF expressed by stimulated HCVE and stromal cells were comparable among cells derived from different valves. Although phenotypic changes in cells may occur during passage, thus limiting the reliance one places on such results, these findings indirectly support the contention, long espoused, that hemodynamic factors play a central role in the localization of endocarditis lesions (41).
These experiments document the potential ability of both constituent cells of human cardiac valve to express TF. HCVE and stromal cells may thus each play an important role in vegetation formation in infective endocarditis and nonbacterial thrombotic endocarditis. Although in vivo studies are needed to confirm investigations with cultured cells, the availability of cardiac valve cells in culture will further our ability to dissect the complex and dynamic aspects of the pathogenesis of endocarditis. 
